Stock Evaluator: Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Ltd. DRTS

$13.23 -0.12 -0.90%
October 29, 2026 4:00:00 PM EST November 10, 2021 Volume: 292,883
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Commentary & Analysis


Financial Summary

Share Statistics DRTS Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,221.6 $425.5 48%
Shares Out (Mil) 91.0 40.4 60%
Institutional Ownership 37.7% 83.0% 16%
Float (Mil) 64.1 34.7 52%
Beta 1.18 0.85 69%
Avg Daily Volume (000s) 498 287 59%
Price Change
(52-week)
215.0% 65.2% 99%
Growth DRTS Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 11.8% na
Net Income (5yr) (36.8%) (5.5%) 11%
EPS (5yr) (19.1%) 10.7% 14
Dividends (5yr) na 0.0% na
Cash Flow (5yr) (15.5%) (15.6%) 48%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 4 5 5
Current EPS ($0.147) ($0.955) ($0.535)
Month Ago EPS ($0.147) ($0.955) ($0.535)
# Rev Up 0 0 0
# Rev Down 1 3 1
Three Months Ago EPS ($0.138) ($0.659) ($0.515)
Year/Year Chg (70.8%) 80.5% (33.8%)
Financials DRTS Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $128 na
Net Income (TTM) (Mil) ($93) ($9) 12%
EPS (TTM) ($1.052) ($0.400) 21%
Operating Cash Flow (TTM) (Mil) ($13) ($2) 18%
Net Cash Flow (TTM) (Mil) na $1 na
Long-Term Debt (Q1) (Mil) $14 $23 30%
Enterprise Value (Q1) (Mil) $1,231 $399 43%
Valuation DRTS Industry
Median
Percentile
(All Stocks)
P/B 27.56 2.49 97%
P/E na 28.5 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 1.5 na
Ratios DRTS Industry
Median
Percentile
(All Stocks)
Gross Margin na 59.3% na
Net Margin na (6.9%) na
ROA (80.4%) (11.8%) 7%
ROE (156.8%) (10.1%) 6%
Liabilities to Assets 67.2% 47.2% 63%
F-Score 1 4 1%

Alpha Tau Medical Ltd. did not pass any screens on 10/29/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors